ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 178

Depression: A Common Comorbidity in Rheumatic Diseases. a Case-Control Study

Dionicio Galarza-Delgado 1, Jose Azpiri-Lopez 1, Iris Colunga-Pedraza 1, Karla Paola Cuellar-Calderon1, Ileana Cecilia Reynosa-Silva 1, Marielva Castro-Gonzalez 1 and Carolina Marlene Martinez-Flores 1, 1Universidad Autonoma de Nuevo Leon, Hospital Universitario "Dr Jose Eleuterio Gonzalez", Monterrey, Nuevo Leon, Mexico

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: depression and rheumatic education, Rheumatic disease

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 10, 2019

Title: Epidemiology & Public Health Poster I: RA

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Depression is a frequent comorbidity in rheumatic diseases (RD) and it is associated with chronic pain and long-term medical treatment in these patients. Furthermore, studies have reported the impact of depression in these population and it is consistently associated with the severity and sensitivity to pain, poor treatment outcomes, disease activity and potentially with early mortality. The Patient Health Questionnaire 9 (PHQ-9) is an extensively validated screening tool. It has several advantages: it is more accurate than other screening tools with 88% of sensitivity and 88% specificity, it is self-applied and able to be used by any clinician. Thus, the aim of this study was to determine the prevalence of depression in a group of RD patients and compare it to non-rheumatic controls.

Methods: An observational, cross-sectional study was designed. Patients were recruited at a community educational healthcare conference. Population was divided into two groups: patients with and without RD. A complete history with information about exercise and the PHQ-9 screening tool were performed to every subject. Subjects without RD were recruited as controls. Descriptive analysis was done using frequencies (%) and median (q25-q75). Comparisons were done using Chi-square and Mann Whitney-U test, considering p < 0.05 as significant.

Results: A total of 257 subjects were included. Demographic characteristics are shown in Table 1. Patients with RD have greater scores of PHQ-9 with a median of 7 points (p25-p75, 3-12) than controls with a median of 4 (q25-q75, 1-9) (p= 0.009). In the case group, 83 patients (32.8%) have diagnosis of depression and 61 (25.3%) of the controls (p= 0.016).
Subjects with an inactive lifestyle have a higher prevalence of depression, being sedentary in both groups has an OR 3.246 (IC 1.92 to 5.47), p< 0.001. Sedentarism is highly significant in controls (p < 0.001), but not in RD (p=0.085).

Conclusion: Patients with RD have a higher prevalence of depression than non-rheumatic subjects. An inactive lifestyle was associated with a higher prevalence of depression in both, those with and without RD. The physicians should be aware of it and use screening tools for early detection and provide a multimodal management.


Table 1 depression

Table 1. Demographic characteristics


Table 2 PHQ

Table 2. Patient Health Questionnaire- 9


Disclosure: D. Galarza-Delgado, None; J. Azpiri-Lopez, None; I. Colunga-Pedraza, None; K. Cuellar-Calderon, None; I. Reynosa-Silva, None; M. Castro-Gonzalez, None; C. Martinez-Flores, None.

To cite this abstract in AMA style:

Galarza-Delgado D, Azpiri-Lopez J, Colunga-Pedraza I, Cuellar-Calderon K, Reynosa-Silva I, Castro-Gonzalez M, Martinez-Flores C. Depression: A Common Comorbidity in Rheumatic Diseases. a Case-Control Study [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/depression-a-common-comorbidity-in-rheumatic-diseases-a-case-control-study/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/depression-a-common-comorbidity-in-rheumatic-diseases-a-case-control-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology